UCB Future Growth

Future criteria checks 4/6

UCB is forecast to grow earnings and revenue by 33% and 12.2% per annum respectively. EPS is expected to grow by 34.4% per annum. Return on equity is forecast to be 17.1% in 3 years.

Key information

33.0%

Earnings growth rate

34.4%

EPS growth rate

Pharmaceuticals earnings growth16.0%
Revenue growth rate12.2%
Future return on equity17.1%
Analyst coverage

Good

Last updated17 Dec 2024

Recent future growth updates

Analysts Have Made A Financial Statement On UCB SA's (EBR:UCB) Half-Yearly Report

Jul 28
Analysts Have Made A Financial Statement On UCB SA's (EBR:UCB) Half-Yearly Report

Recent updates

Why We're Not Concerned About UCB SA's (EBR:UCB) Share Price

Oct 22
Why We're Not Concerned About UCB SA's (EBR:UCB) Share Price

These 4 Measures Indicate That UCB (EBR:UCB) Is Using Debt Reasonably Well

Sep 10
These 4 Measures Indicate That UCB (EBR:UCB) Is Using Debt Reasonably Well

Analysts Have Made A Financial Statement On UCB SA's (EBR:UCB) Half-Yearly Report

Jul 28
Analysts Have Made A Financial Statement On UCB SA's (EBR:UCB) Half-Yearly Report

Investors Still Waiting For A Pull Back In UCB SA (EBR:UCB)

Jul 15
Investors Still Waiting For A Pull Back In UCB SA (EBR:UCB)

Shareholders Will Probably Not Have Any Issues With UCB SA's (EBR:UCB) CEO Compensation

Apr 19
Shareholders Will Probably Not Have Any Issues With UCB SA's (EBR:UCB) CEO Compensation

Is UCB (EBR:UCB) A Risky Investment?

Mar 27
Is UCB (EBR:UCB) A Risky Investment?

Earnings Tell The Story For UCB SA (EBR:UCB) As Its Stock Soars 26%

Mar 04
Earnings Tell The Story For UCB SA (EBR:UCB) As Its Stock Soars 26%

UCB SA's (EBR:UCB) P/E Is On The Mark

Dec 28
UCB SA's (EBR:UCB) P/E Is On The Mark

Earnings and Revenue Growth Forecasts

ENXTBR:UCB - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20267,6381,3362,0812,26615
12/31/20256,7869271,6201,81616
12/31/20245,8176091,3641,45416
6/30/20245,454240569889N/A
3/31/20245,318292507825N/A
12/31/20235,182343445761N/A
6/30/20235,111332620975N/A
3/31/20235,2793766841,047N/A
12/31/20225,4474207481,119N/A
6/30/20225,8548879821,462N/A
3/31/20225,8169711,0211,508N/A
12/31/20215,7771,0551,0601,553N/A
9/30/20215,6479969071,371N/A
6/30/20215,5179367541,188N/A
3/31/20215,4328347431,135N/A
12/31/20205,3477327321,081N/A
6/30/20205,198743706908N/A
3/31/20205,056767647895N/A
12/31/20194,913790588882N/A
6/30/20194,686652677950N/A
3/31/20194,6597227131,020N/A
12/31/20184,6327927481,089N/A
6/30/20184,5698727111,092N/A
3/31/20184,522812N/A1,010N/A
12/31/20174,474752N/A927N/A
9/30/20174,400708N/AN/AN/A
6/30/20174,325664N/A780N/A
3/31/20174,236604N/A604N/A
12/31/20164,147543N/A427N/A
9/30/20164,051439N/AN/AN/A
6/30/20163,955334N/A66N/A
3/31/20163,916299N/A156N/A
12/31/20153,876264N/A246N/A
9/30/20153,773266N/A388N/A
6/30/20153,670268N/A530N/A
3/31/20153,507192N/A541N/A
12/31/20143,344115N/A552N/A
9/30/20143,206114N/A507N/A
6/30/20143,067112N/A462N/A
3/31/20143,10097N/A375N/A
12/31/20133,13382N/A288N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: UCB's forecast earnings growth (33% per year) is above the savings rate (1.4%).

Earnings vs Market: UCB's earnings (33% per year) are forecast to grow faster than the Belgian market (21.1% per year).

High Growth Earnings: UCB's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: UCB's revenue (12.2% per year) is forecast to grow faster than the Belgian market (7.4% per year).

High Growth Revenue: UCB's revenue (12.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: UCB's Return on Equity is forecast to be low in 3 years time (17.1%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:33
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

UCB SA is covered by 48 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark van der GeestABN AMRO Bank N.V.
Kamla SinghAlphaValue
Brian BourdotBarclays